Allogene Therapeutics Inc (ALLO)

Mar 19, 2025

H.C. Wainwright cuts Allogene stock target to $8, keeps Buy rating By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

H.C. Wainwright cuts Allogene stock target to $8, keeps Buy rating - Investing.com India

Mar 19, 2025

Mar 19, 2025

Allogene Therapeutics CEO sells $91,469 in stock By Investing.com - Investing.com Australia

Mar 19, 2025

Mar 18, 2025

Allogene Therapeutics CEO sells $91,469 in stock - Investing.com India

Mar 18, 2025

Mar 18, 2025

Allogene Therapeutics Executives Sell Shares for Tax Obligations - TradingView

Mar 18, 2025

Mar 18, 2025

Renal Cancer Clinical Pipeline | 75+ Companies, Including - openPR.com

Mar 18, 2025

Mar 17, 2025

7th Annual Allogeneic Cell Therapies Summit - pharmaphorum

Mar 17, 2025

Mar 17, 2025

Allogene Therapeutics' SWOT analysis: CAR-T pioneer's stock faces pivotal year - Investing.com

Mar 17, 2025

Mar 17, 2025

Allogene Therapeutics’ SWOT analysis: CAR-T pioneer’s stock faces pivotal year - Investing.com India

Mar 17, 2025

Mar 17, 2025

Allogeneic T Cell Therapies Market Set For 9.8% Growth, Reaching $1.9 Billion By 2029 - WhaTech

Mar 17, 2025

Mar 16, 2025

Allogene upgraded at Citizens after Q4 update - MSN

Mar 16, 2025

Mar 15, 2025

Allogene Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Mar 15, 2025

Mar 15, 2025

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 15, 2025

Mar 14, 2025

Allogene Therapeutics Inc (ALLO) Q4 2024 Earnings Call Highlights: Financial Challenges Amid ... By GuruFocus - Investing.com Canada

Mar 14, 2025

Mar 14, 2025

Citizens Capital Markets Upgrades Allogene Therapeutics (ALLO) - Nasdaq

Mar 14, 2025

Mar 14, 2025

Allogene Therapeutics Inc (ALLO) Q4 2024 Earnings Call Highlights: Financial Challenges Amid ... - Yahoo

Mar 14, 2025

Mar 14, 2025

Allogene Therapeutics Inc (ALLO) Q4 2024 Earnings Call Highlight - GuruFocus.com

Mar 14, 2025

Mar 14, 2025

Citi maintains Buy on Allogene stock with $8 price target By Investing.com - Investing.com Australia

Mar 14, 2025

Mar 14, 2025

Allogene stock upgraded at Citizens post Q4 (ALLO:NASDAQ) - Seeking Alpha

Mar 14, 2025

Mar 14, 2025

Citi maintains Buy on Allogene stock with $8 price target - Investing.com India

Mar 14, 2025

Mar 14, 2025

Allogene's Q4 Loss Narrower Than Expected, Revenues Nil - Yahoo Finance

Mar 14, 2025

Mar 14, 2025

Allogene Therapeutics: Q4 Earnings Snapshot - The Wilton Bulletin

Mar 14, 2025

Mar 13, 2025

Earnings call transcript: Allogene’s Q4 2024 earnings beat expectations By Investing.com - Investing.com South Africa

Mar 13, 2025

Mar 13, 2025

Earnings call transcript: Allogene’s Q4 2024 earnings beat expectations - Investing.com India

Mar 13, 2025

Mar 13, 2025

Allogene Therapeutics Inc Q4 Loss Per Share $0.28 -March 13, 2025 at 05:32 pm EDT - Marketscreener.com

Mar 13, 2025

Mar 13, 2025

Allogene Therapeutics Inc Reports Q4 2024 EPS of -$0.28, Beating Estimates; Revenue Falls Short - GuruFocus.com

Mar 13, 2025

Mar 13, 2025

Allogene Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 13, 2025

Mar 13, 2025

ALLOGENE THERAPEUTICS Earnings Results: $ALLO Reports Quarterly Earnings - Nasdaq

Mar 13, 2025

Mar 13, 2025

Allogene Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update - The Manila Times

Mar 13, 2025

Mar 13, 2025

Allogene Therapeutics: Q4 Earnings Snapshot -March 13, 2025 at 05:05 pm EDT - Marketscreener.com

Mar 13, 2025

Mar 08, 2025

Allogene Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire

Mar 08, 2025

Mar 05, 2025

CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain - Yahoo Finance

Mar 05, 2025

Mar 05, 2025

CAR T-cell Therapy Clinical Trial Pipeline Experiences - GlobeNewswire

Mar 05, 2025

Mar 03, 2025

Foresight Diagnostics expands Allogene partnership - BizWest

Mar 03, 2025

Mar 03, 2025

Allogene Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update - The Manila Times

Mar 03, 2025

Mar 03, 2025

When Will Allogene Reveal Its CAR T Progress? Key Earnings Date Set - StockTitan

Mar 03, 2025

Mar 03, 2025

Allogene Therapeutics Schedules Conference Call and Webcast for Q4 and Full Year 2024 Financial Results on March 13, 2025 - Nasdaq

Mar 03, 2025

Feb 27, 2025

Foresight Diagnostics Expands Strategic Partnership with Allogene Therapeutics to Advance Joint Development Activities Outside of the U.S. Across Europe, UK, Canada and Australia - The Malaysian Reserve

Feb 27, 2025

Feb 27, 2025

Allogene Short Interest Reportedly Near 5-Year Lows Amid Growing Retail Optimism: Analyst Sees CAR-T Therapy Promise - MSN

Feb 27, 2025

Feb 26, 2025

Allogene: Assessing The Pipeline, Competitive Landscape, And Opportunities (NASDAQ:ALLO) - Seeking Alpha

Feb 26, 2025

Feb 26, 2025

Allogene Expands Partnership With Foresight Diagnostics To Advance Cema-Cel Development Globally - Nasdaq

Feb 26, 2025

Feb 26, 2025

Allogene Therapeutics Announces Participation in March Investor Conference - The Manila Times

Feb 26, 2025